Lernzettel: Understanding French Medicine Regulations

📋 Course Outline

1. Legal definition and regulatory status of medicines in France
2. Distinction between medicines, dietary supplements, and cosmetics
3. Marketing authorization (AMM) process and criteria for pharmaceutical specialties
4. Classification and prescription rules for medicines including controlled substances
5. Prescription requirements and special prescription forms for exceptional medicines
6. Generic medicines: definition, bioequivalence, and substitution rights
7. Biological medicines, biosimilars, and biotechnological drug examples
8. Medicines prepared extemporaneously: officinal, magistral, and hospital preparations

📖 1. Legal definition and regulatory status of medicines in France

🔑 Key Concepts & Definitions

• DEFINITION ORIGINE STATUT DU MEDICAMENT : A legal category defined by article L.5111-1 CSP that includes any substance or composition presented as having curative or preventive properties against human or animal diseases, or used for diagnosis or to restore, correct, or modify physiological functions through pharmacological, immunological, or metabolic action.

📝 Essential Points

• The legal definition encompasses substances of chemical or plant origin intended for diagnosis, prevention, treatment, or physiological function modification.
• A medicine is any substance or composition presented as having curative or preventive properties against human or animal diseases or used for diagnosis or physiological function modification by pharmacological, immunological, or metabolic action.

💡 Key Takeaway

Understanding the precise legal definition of medicines is fundamental to grasping their regulatory framework and obligations in France.

📖 2. Distinction between medicines, dietary supplements, and cosmetics

🔑 Key Concepts & Definitions

Dietary supplements are products intended to supplement the diet and contribute to maintaining health in individuals who are not ill. Cosmetics are products related to health but are not classified as medicines and do not make therapeutic claims. Therapeutic properties refer to effects aimed at treating or preventing diseases, whereas nutritional or physiological properties involve supporting normal bodily functions without targeting illness.

📝 Essential Points

• Medicines are designed to treat or prevent diseases and are targeted at individuals who are sick or potentially sick. In contrast, dietary supplements focus on supporting well-being in healthy individuals. The regulatory process differs: medicines require an authorization to market (AMM) from the ANSM, while dietary supplements only need to be declared to consumer protection authorities. A dose-dependent distinction exists; for example, vitamin C intake above 500 mg is considered a medicine, whereas lower doses are classified as dietary supplements.

💡 Key Takeaway

Differentiating medicines from dietary supplements and cosmetics depends on their intended use, target population, and the regulatory authorization required.

📖 3. Marketing authorization (AMM) process and criteria for pharmaceutical specialties

🔑 Key Concepts & Definitions

Pharmaceutical specialties are industrially manufactured medicines that are prepared in advance, distinguished by a specific denomination and particular packaging. The Marketing Authorization (AMM) is a formal approval granted to these medicines, allowing their distribution and use. The AMM dossier comprises comprehensive data on the pharmaceutical properties, pharmacological and toxicological assessments, as well as clinical trial information. This authorization is granted only if the medicine demonstrates efficacy, safety, and quality for designated indications and routes of administration. The control and regulation of the AMM process are conducted by the ANSM in France and by the EMA at the European level.

📝 Essential Points

• Pharmaceutical specialties are characterized by their pre-manufactured, industrial production, and are identified through a specific name and packaging. The AMM dossier must include detailed pharmaceutical, pharmaco-toxicological, and clinical data to support the medicine’s approval. The authorization process evaluates whether the medicine meets the criteria of efficacy, safety, and quality, specifically for the intended indications and routes of administration. The granting of the AMM is subject to strict oversight by regulatory agencies, with ANSM responsible in France and EMA at the European level.

💡 Key Takeaway

The AMM process ensures that pharmaceutical specialties meet rigorous standards of efficacy, safety, and quality before they are authorized for market entry, with oversight by relevant regulatory authorities.

📖 4. Classification and prescription rules for medicines including controlled substances

🔑 Key Concepts & Definitions

• Règles particulières de prescription : specific regulations governing how certain medicines must be prescribed, often based on their classification, risk level, or therapeutic context.

• prescription Quantité délivrée Stupéfiants ordonnance : rules determining the duration, quantity, and security requirements of prescriptions for controlled substances, particularly stupéfiants, which require a secured prescription valid from 7 to 28 days depending on the substance and form.

📝 Essential Points

• Medicines are categorized according to their risk profile: OTC (Over The Counter) medicines can be dispensed freely without a prescription; List II medicines, which are veneneous and marked by a green-lined packaging, require a prescription; List I medicines, which are toxic and marked by a red-lined packaging, also require a prescription with limits on renewal; and Stupefiants, which are controlled substances, must be dispensed with a secured prescription.

• Stupefiants prescriptions must be secured and are valid for a period ranging from 7 to 28 days, depending on the specific substance and pharmaceutical form.

• Medicines may have restricted prescription categories such as reserve hospitalière (RH), prescription hospitalière (PH), prescription initiale hospitalière (PIH), prescription réservée à spécialistes (PRS), and those requiring special surveillance (SP).

• The duration and renewal rules for prescriptions vary by classification: List I medicines can be prescribed for up to 12 months in 30-day fractions unless otherwise specified; they are generally non-renewable unless explicitly stated. List II medicines are typically prescribed with simple, renewable prescriptions, limited to 12 months in 30-day fractions unless specified otherwise.

• Medicines outside these classifications, not listed, are available over the counter in pharmacies without the need for a prescription.

• Pharmacists are required to adhere strictly to classification and prescription rules when dispensing medicines, ensuring proper access based on the risk and therapeutic context.

📖 5. Prescription requirements and special prescription forms for exceptional medicines

🔑 Key Concepts & Definitions

• Prescription en rapport avec : a medical order that must be issued in accordance with specific regulations for controlled or exceptional medicines, ensuring proper documentation and compliance with therapeutic guidelines.

• Prescription en rapport : a medical order related to exceptional medicines that must adhere to particular forms and conditions, especially when involving medicines with strict use restrictions or reimbursement procedures.

📝 Essential Points

• Stupefiants must be prescribed on a secure prescription form that includes detailed information such as the quantity, dose, and units. This form ensures precise documentation and control over the medication dispensed.

• Exceptional medicines require the use of special prescription forms that consist of four copies. These copies are designated for the patient, the insurance provider, and the pharmacy, facilitating proper record-keeping and reimbursement processes.

• Prescriptions for exceptional medicines must comply with therapeutic information sheets (FIT). When the prescription aligns with the indications specified in the FIT, it qualifies for reimbursement by the health insurance. Conversely, prescriptions for indications outside the FIT use standard prescriptions but are not reimbursed.

• The validity of prescriptions and the limits on dispensing are strictly regulated. For example, stupéfiants must be dispensed within three days of the prescription date, and the entire prescription must be executed within the specified timeframe. If the prescription is not fully used within this period, only the remaining quantity can be dispensed, and no new prescription is allowed from the same practitioner during the covered period unless exceptions apply.

💡 Key Takeaway

Strict requirements for special prescription forms and detailed regulations on prescription validity and dispensing ensure the safe, controlled, and compliant use of exceptional and controlled medicines.

📖 6. Generic medicines: definition, bioequivalence, and substitution rights

🔑 Key Concepts & Definitions

• Bioequivalence : A pharmacokinetic demonstration that the exposure to the active ingredient of a generic medicine leads to the same therapeutic effects as the original medicine, with 90% confidence intervals for pharmacokinetic parameters included within 80%-125%, or within 90%-111% for drugs with a narrow therapeutic index.
• PARIS CITÉ : A university that provides the educational content related to generic medicines and pharmaceutical regulations.

📝 Essential Points

• Generic medicines have the same qualitative and quantitative composition in active ingredients and pharmaceutical form as the original (princeps) medicine.
• Bioequivalence is demonstrated by pharmacokinetic studies with 90% confidence intervals within 80%-125%, or 90%-111% for narrow therapeutic index drugs.

💡 Key Takeaway

Generic medicines provide cost-effective alternatives by demonstrating bioequivalence and enabling pharmacist substitution.

📖 7. Biological medicines, biosimilars, and biotechnological drug examples

🔑 Key Concepts & Definitions

• Code de la Santé publique : A legal framework in France that regulates health products, including medicines and biological products, specifying production and authorization standards.

📝 Essential Points

• Biosimilars differ from generics in raw materials, production processes, modes of action, and authorization procedures.
• Biological medicines are complex products derived from biological sources including vaccines, blood derivatives, and biotechnological products like monoclonal antibodies.

💡 Key Takeaway

Biological medicines and biosimilars represent a distinct category requiring specialized production and regulatory approaches different from chemical generics.

📖 8. Medicines prepared extemporaneously: officinal, magistral, and hospital preparations

🔑 Key Concepts & Definitions

Officinal preparations are extemporaneous medicines prepared directly in pharmacies according to pharmacopoeia or national formularies, and must adhere to good preparation practices.

Magistral preparations are customized medicines made for a specific patient based on a medical prescription, with details recorded in a register.

Hospital preparations are medicines prepared within hospital pharmacies for hospitalized or ambulatory patients, often for groups when no commercial specialty exists.

CITÉ Préparation refers to hospital preparations made in hospital pharmacies for patients, often when no commercial options are available.

📝 Essential Points

• Officinal preparations are prepared extemporaneously in pharmacies following the composition listed in the pharmacopoeia européenne or the national formulary. They are prepared under the authority of the Ministry of Health, which mandates that pharmacists possess the latest editions. These preparations serve as standards for identifying and dosing substances and must follow good preparation practices.

• Magistral preparations are formulated specifically for an individual patient based on a medical prescription. They are prepared extemporaneously in pharmacies, with the formulation defined by the prescribing doctor, and recorded in a register. All magistral preparations must comply with good preparation practices.

• Hospital preparations are made in hospital pharmacies either in advance or on demand, for hospitalized or ambulatory patients. They are often intended for groups, especially when no commercial specialty is available, such as in cases of specific dosage needs like pediatric formulations. These preparations are made in the pharmacy of a healthcare facility.

• All extemporaneous preparations, whether officinal, magistral, or hospital, must adhere to good preparation practices and official standards. Pharmacists are responsible for maintaining up-to-date pharmacopoeia editions and ensuring traceability of magistral preparations.

💡 Key Takeaway

Extemporaneous preparations provide personalized or unavailable medicines within pharmacy and hospital settings, strictly regulated to ensure quality and safety through adherence to official standards and good practices.

📊 Synthesis Tables

Comparison of Medicine Categories in France

Category	Definition	Regulatory Process
Medicines	Substances with curative, preventive, or diagnostic properties, or modifying physiological functions	Require AMM approval based on efficacy, safety, and quality
Dietary Supplements	Products supporting health in healthy individuals, not classified as medicines	No AMM required, regulated as food supplements
Cosmetics	Products related to health but not therapeutic, without claims to treat diseases	Regulated as cosmetic products, no therapeutic claims

Prescription Rules for Medicines in France

Medicine Type	Prescription Duration	Renewal Rules
List I medicines	Up to 12 months in 30-day fractions	Generally non-renewable unless specified
List II medicines	Up to 12 months in 30-day fractions	Renewable with simple prescriptions
Over-the-counter medicines	No prescription required	Available without prescription

⚠️ Common Pitfalls & Confusions

1. Confusing the legal definition of medicines with their pharmacological properties.
2. Misunderstanding the distinction between dietary supplements and medicines.
3. Assuming all biological products are generic medicines.
4. Mixing up the prescription rules for List I and List II medicines.
5. Overlooking the specific requirements for prescriptions of exceptional medicines.
6. Incorrectly assuming bioequivalence applies to all generic medicines without proper studies.
7. Confusing biosimilars with generic medicines.

✅ Exam Checklist

1. Understand the legal definition of medicines in France.
2. Differentiate between medicines, dietary supplements, and cosmetics.
3. Learn the process and criteria for obtaining an AMM.
4. Know the classification and prescription rules for medicines.
5. Familiarize with special prescription forms for exceptional medicines.
6. Understand bioequivalence and substitution rights for generics.
7. Identify biological medicines and biosimilars.
8. Recognize types of extemporaneous preparations: officinal, magistral, hospital.
9. Comprehend the regulatory standards for biological medicines.
10. Distinguish between hospital and community extemporaneous preparations.
11. Be aware of the oversight roles of ANSM and EMA.
12. Learn the specific rules for controlled substances.